Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 8975-8979, October 1, 2007. doi: 10.1158/0008-5472.CAN-07-1328
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Neill, G. M.
Right arrow Articles by Golemis, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Neill, G. M.
Right arrow Articles by Golemis, E. A.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Invasion and Metastasis

Reviews

A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9

Geraldine M. O'Neill1,2, Sachiko Seo3, Ilya G. Serebriiskii4, Stuart R. Lessin4 and Erica A. Golemis4

1 Oncology Research Unit, The Children's Hospital at Westmead, NSW, Australia; 2 Discipline of Paediatrics and Child Health, The University of Sydney, NSW, Australia; 3 Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; and 4 Fox Chase Cancer Center, Philadelphia, Pennsylvania

Requests for reprints: Erica A. Golemis, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. Phone: 215-728-2860; Fax: 215-728-3616; E-mail: EA_Golemis{at}fccc.edu.

Greater understanding of metastasis is required to improve cancer treatment outcomes. Recently, changes in expression of the scaffold protein HEF1/CAS-L/NEDD9 were found to be a potent prometastatic stimulus in melanoma and other cancers. Mechanistic studies suggest diverse cellular roles of HEF1 and highlight its importance in the response to extracellular cues that drive invasion and metastasis. As a metastatic "hub" for signaling in cancer, HEF1 may provide a useful target for drug discovery efforts. [Cancer Res 2007;67(19):8975–9]




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Ganesan, T. Ivanova, Y. Wu, V. Rajasegaran, J. Wu, M. H. Lee, K. Yu, S. Y. Rha, H. C. Chung, B. Ylstra, et al.
Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel {beta}-Catenin/TCF Target Gene
Cancer Res., June 1, 2008; 68(11): 4277 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. K. Singh, D. Dadke, E. Nicolas, I. G. Serebriiskii, S. Apostolou, A. Canutescu, B. L. Egleston, and E. A. Golemis
A Novel Cas Family Member, HEPL, Regulates FAK and Cell Spreading
Mol. Biol. Cell, April 1, 2008; 19(4): 1627 - 1636.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.